Search

Sandor R Karady

from Mountainside, NJ
Age ~91
Get Report
Also known as:
Sendor Karady
Phone and address:
348 Longview Dr, Mountainside, NJ 07092
(908) 233-7315
Related to:
Jennifer Karady, 58Ondine Karady, 55Ivi Karady, 88
Connected to:
Dolores R Karadzas, 59Jasminka Karadza, 59Kathy R Karadza, 48Marko Karadzic, 48Marina Karaeva, 70Frank J Karafa, 50John E Karafa, 62Kathy Karafa, 41Maria KarafaMark G Karafa, 58

Sandor Karady Phones & Addresses

  • 348 Longview Dr, Mountainside, NJ 07092 (908) 233-7315
  • 75 Roebling St, Brooklyn, NY 11211 (718) 388-2771
  • New York, NY
  • Saint Charles, MO
  • Flushing, NY

Work

Position: Clerical/White Collar

Education

Degree: High school graduate or higher

Resumes

Resumes

Sandor Karady Photo 1

Sandor Karady

View page
Sandor Karady Photo 2

Accounting Professional

View page
Location:
Greater New York City Area
Industry:
Accounting

Publications

Us Patents

Piperazine Carboxamide Intermediates Of Hiv Protease Inhibitors And Processes For Their Preparation

View page
US Patent:
20030191121, Oct 9, 2003
Filed:
Aug 6, 2002
Appl. No.:
10/212978
Inventors:
Ross Miller - Fanwood NJ, US
Sandor Karady - Mountainside NJ, US
Paul Reider - Westfield NJ, US
International Classification:
A61K031/541
A61K031/5377
A61K031/498
C07D487/02
US Classification:
514/228500, 514/234200, 514/249000, 544/060000, 544/117000, 544/350000
Abstract:
Piperazine carboxamide intermediates of HIV protease inhibitors and a process for their preparation are disclosed. The piperazine carboxamide compounds are of Formula (III): wherein R, R, R, R, R, and Rare defined herein. The process for preparing the intermediates comprises coupling an iminium salt of Formula I: with a metallated derivative of a compound of Formula (II): wherein L is a counterion. A process for preparing the iminium salt of Formula (I) is also disclosed, as is a process for preparing HIV protease inhibitors from Compound III.

Process For The Preparation Of 2,2-Disubstituted Pyrroles

View page
US Patent:
20070225499, Sep 27, 2007
Filed:
Apr 15, 2005
Appl. No.:
11/578756
Inventors:
Gary Javadi - West Windsor NJ, US
Sandor Karady - Mountainside NJ, US
Kenji Maeda - Okazaki, JP
Ross Miller - Fanwood NJ, US
Ronald Szumigala - Somerville NJ, US
International Classification:
C07D 207/16
C07D 211/58
C07D 263/04
C07D 263/52
US Classification:
546208000, 548221000, 548565000
Abstract:
p-00010000

7-.Alpha.-Methoxy Cephalosporins

View page
US Patent:
42974887, Oct 27, 1981
Filed:
Jun 2, 1971
Appl. No.:
5/149364
Inventors:
Burton G. Christensen - Scotch Plains NJ
Lovji D. Cama - Edison NJ
Sandor Karady - Elizabeth NJ
Meyer Sletzinger - North Plainfield NJ
Assignee:
Merck & Co., Inc. - Rahway NJ
International Classification:
C07D50157
A61K 31545
US Classification:
544 21
Abstract:
Process and intermediate products useful in the preparation of cephalosporin compounds having a substituent at the 7-position in place of hydrogen are provided. The new cephalosporin compounds are active against various gram-negative and gram-positive organisms.

3-Substituted Methyl-7-Acylamino-7-Methoxy-2-Cephem-4-Carboxylic Acid And Its Esters

View page
US Patent:
39870405, Oct 19, 1976
Filed:
Dec 5, 1974
Appl. No.:
5/529863
Inventors:
Theresa Y. Cheng - Newark NJ
Sandor Karady - Elizabeth NJ
Seemon H. Pines - Murray Hill NJ
Meyer Sletzinger - North Plainfield NJ
Assignee:
Merck & Co., Inc. - Rahway NJ
International Classification:
C07D50160
US Classification:
260243C
Abstract:
Process for preparing an ester of 3-substituted methyl-7-acylamido-7-methoxy(or hydrogen)-2-cephem-4-carboxylic acid and its corresponding sulfoxide by treating an ester of 3-carbamoyloxymethyl(or 3-lower alkanoyloxymethyl)-7-acylamido-7-methoxy(or hydrogen)-2-cephem-4-carboxyli c acid with a hydrohalic acid or another compound containing an active hydrogen and then with an oxidizing agent. The products obtained are useful as intermediates in the preparation of antibiotics.

Preparation Of An Enantiomer Of A Substituted Fluorenyloxyacetic Acid

View page
US Patent:
47044721, Nov 3, 1987
Filed:
Dec 18, 1985
Appl. No.:
6/797311
Inventors:
Robin S. E. Conn - Westfield NJ
Sandor Karady - Mountainside NJ
Assignee:
Merck & Co., Inc. - Rahway NJ
International Classification:
C07C 5976
C07C 6534
US Classification:
562461
Abstract:
A process for direct preparation of an enantiomer of a substituted fluorenyloxyacetic acid is disclosed. The acetic acid derivative is useful for treating brain edema.

Silyl, Benzyl, P-Nitrobenyl, Or Methyl Esters Of Diazoacetate, A Synthon Used In The Conversion Of Penicillin To Thienamycin

View page
US Patent:
45255822, Jun 25, 1985
Filed:
Jan 23, 1984
Appl. No.:
6/572794
Inventors:
Joseph S. Amato - Brooklyn NY
Sandor Karady - Mountainside NJ
Leonard M. Weinstock - Belle Mead NJ
Assignee:
Merck & Co., Inc. - Rahway NJ
International Classification:
C07C11300
US Classification:
534558
Abstract:
A novel synthon useful in the conversion of penicillin is a compound of the formula ##STR1## wherein R. sub. 3 is a number of the group consisting of trimethyl-silyl, t-butyl dimethyl silyl, trimethyl silyl, methyl, benzyl or nitrobenzyl, and R. sub. 5 is the same or different member of the group R. sub. 3 is prepared by the naphthalene sulfonyl azide exchange reaction with benzyl acetoacetate, p-nitrobenzylacetoacetate, or methylacetoacetate to obtain the corresponding 2-diazo compound which is then silylated in hexamethyl-disalazine.

Process For 5-Methyl-10,11-Dihydro-5H-Dibenzo[A,D]-Cyclohepten-5,10-Imine

View page
US Patent:
44776683, Oct 16, 1984
Filed:
Sep 3, 1982
Appl. No.:
6/414739
Inventors:
Dean R. Bender - Hazlet NJ
Sandor Karady - Mountainside NJ
Theresa Rothauser - Clark NJ
Assignee:
Merck & Co., Inc. - Rahway NJ
International Classification:
C07D47108
US Classification:
546 72
Abstract:
(+)-5-Methyl-10,11-dihydro-5H-dibenzo[a,d]-cyclohepten-5,10-imine, and its pharmaceutically acceptable salts is useful as an anxiolytic, antidepressant, anticonvulsant, muscle relaxant and in the treatment of mixed anxiety-depression, minimal brain dysfunction and extrapyramidal disorders such as Parkinson's disease. The racemate of the compound is produced by a four-step synthetic process in about 65% yield from 5H-dibenzo[a,d]cyclohepten-5-one.

Trialkylsilyl Trifluoromethanesulfonate Mediated .Alpha.-Methylenic Carbon Functionalization Of 4-Aza-5.Alpha.-Androstan-3-One Steroids

View page
US Patent:
51872781, Feb 16, 1993
Filed:
Nov 1, 1991
Appl. No.:
7/786615
Inventors:
Anthony O. King - Hillsboro NJ
Kevin Anderson - Plainsboro NJ
Sandor Karady - Mountainside NJ
Alan W. Douglas - Monmouth Junction NJ
Newton L. Abramson - Edison NJ
Richard F. Shuman - Westfield NJ
Assignee:
Merck & Co., Inc. - NJ
International Classification:
C07J 7300
US Classification:
546 14
Abstract:
A novel single-pot trialkylsilyl trifluoromethanesulfonate (R. sub. 3 Si-OTf) mediated process produces derivatives of 4-aza 3-keto steroids at the. alpha. -methylenic carbon through electrophilic substitution. These derivatives are useful in the preparation, through elimination of the substituent on the. alpha. -methylene carbon, of. DELTA. -1 olefin 4-aza 3-keto steroids which are potent inhibitors of 5-. alpha. reductase.
Control profile
Sandor R Karady from Mountainside, NJ, age ~91 Get Report